An Australian biotech company is already turning heads so far on Wednesday after it was announced results from its GBM-AGILE, which is a phase II/III study that included an...

To read the full story on AllPennyStocks.com, click here.

Kazia Therapeutics (NASDAQ:KZIA)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025 Click aqui para mais gráficos Kazia Therapeutics.
Kazia Therapeutics (NASDAQ:KZIA)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025 Click aqui para mais gráficos Kazia Therapeutics.